Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volume: 73

Issue: 7

Year of Publication: 2021

Affiliated Institutions:  Graduate School of Social Work, Touro College and University System, New York, New York, USA. Dahdaleh Institute of Global Health Research, School of Global Health, York University, Toronto, Canada. Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, New York, USA. Vagelos College of Physician and Surgeons, Columbia University, New York, New York, USA. Center for the AIDS Programme of Research in South Africa, Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit (CAPRISA MRC-HIV-TB), Durban, South Africa. Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York, USA. Department of Family Medicine, McGill University, Montreal, Canada. University of Michigan School of Public Health, Ann Arbor, Michigan, USA. Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa. University of Kwazulu-Natal, Durban, South Africa. Yale School of Medicine, New Haven, Connecticut, USA.

Abstract summary 

In generalized drug-resistant tuberculosis (DR-TB) human immunodeficiency virus (HIV) epidemics, identifying subpopulations at high risk for treatment failure and loss to care is critically important to improve treatment outcomes and prevent amplification of drug resistance. We hypothesized that an electronic dose-monitoring (EDM) device could empirically identify adherence-challenged patients and that a mixed-methods approach would characterize treatment challenges.A prospective study of patients with DR-TB HIV on antiretroviral therapy (ART) initiating bedaquiline-containing regimens in KwaZulu-Natal, South Africa. Separate EDM devices measured adherence for bedaquiline and ART. Patients with low adherence (<85%) to both bedaquiline and ART were identified as high risk for poor outcomes. Baseline survey, study visit notes, and focus group discussions characterized treatment challenges.From December 2016-February 2018, 32 of 198 (16%) enrolled patients with DR-TB HIV were identified as dual-adherence challenged. In a multivariate model including baseline characteristics, only receiving a disability grant was significantly associated with dual nonadherence at 6 months. Mixed-methods identified treatment barriers including alcohol abuse, family conflicts, and mental health issues. Compared with adherent patients, dual-adherence-challenged patients struggled to prioritize treatment and lacked support, and dual-adherence-challenged patients experienced higher rates of detectable HIV viral load and mortality than more adherent patients.EDM empirically identified a subpopulation of patients with DR-TB HIV with dual-adherence challenges early in treatment. Mixed-methods revealed intense psychosocial, behavioral, and structural barriers to care in this subpopulation. Our data support developing differential, patient-centered, adherence support interventions focused on psychosocial and structural challenges for subpopulations of at-risk DR-TB HIV patients.

Authors & Co-authors:  Zelnick Jennifer R JR Daftary Amrita A Hwang Christina C Labar Amy S AS Boodhram Resha R Maharaj Bhavna B Wolf Allison K AK Mondal Shinjini S Amico K Rivet KR Orrell Catherine C Seepamore Boitumelo B Friedland Gerald G Padayatchi Nesri N O'Donnell Max R MR

Study Outcome 

Source Link: Visit source

Statistics
Citations :  World Health Organization. Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization, 2019.
Authors :  14
Identifiers
Doi : 10.1093/cid/ciaa1557
SSN : 1537-6591
Study Population
Male,Female
Mesh Terms
Antitubercular Agents
Other Terms
South Africa;adherence;drug-resistant TB/HIV;mixed-methods;person-centered care
Study Design
Cross Sectional Study
Study Approach
Country of Study
South Africa
Publication Country
United States